P. Schratzberger et al., Mediator-dependent effects of pentoxifylline on endothelium for transmigration of neutrophils, IMMUNOPHARM, 41(1), 1999, pp. 65-75
In the present study, we investigated the effects of the anti-inflammatory
drug pentoxifylline (PTX) on activation of endothelial cells for enhanced a
dhesion and transmigration of neutrophils by lipopolysaccharide (LPS), tumo
r necrosis factor-alpha (TNF), interleukin-1 (IL-1) and granulocyte colony-
stimulating factor (G-CSF). To evaluate the mechanism by which PTX exerts i
ts effect, human umbilical vein endothelial cells (HUVEC) were pretreated w
ith theophylline, 2'-O-dibutyryl-3', T-cyclic adenosine monophosphate (db c
AMP), and 3-isobutyl-1-methylxanthine, respectively, prior to stimulation.
Pretreatment of HUVEC with PTX significantly antagonized TNF-, IL-1-, and G
-CSF-activated transmigration of neutrophils. Additive stimulatory effects
of PTX were seen with LPS. With the exception of theophylline, all other te
st cAMP-raising agents stimulated transmigration in similar fashion to PTX.
Upon stimulation with TNF or LPS, HUVEC produced IL-8 and PTX affected thi
s process in opposing fashions, with inhibition of the effects of TNF and a
ugmentation of those of LPS. These results demonstrate that PTX differentia
lly affects mediator-induced activation of HUVEC. The present IL-8 dependen
t and cAMP-regulated augmentation of LPS-induced stimulation of transmigrat
ion is the first description of an additive effect of PTX with a pro-inflam
matory agent. (C) 1999 Elsevier Science B.V. All rights reserved.